InvestSMART

Universal Store Holdings Limited (ASX: UNI) - Announcements

Current share price for UNI : $7.470 0.08 (1.06%)+

ASX company news and announcements for Universal Store Holdings Limited (UNI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Universal Store Holdings Limited (UNI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Universal Store Holdings Limited (UNI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Universal Store Holdings Limited (UNI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$573 Unilife and sanofi-aventis Sign Industrialisation Agreement 1 Jul 2009 10:45AM $0.345 $7.470 risen by 2,065.22%
$573 Trading Halt 30 Jun 2009 9:14AM n/a $7.470 n/a
$573 Appendix 4C - quarterly 30 Apr 2009 3:16PM $0.295 $7.470 risen by 2,432.20%
$573 Unilife Medical Solutions - Media Release 6 Apr 2009 10:21AM $0.270 $7.470 risen by 2,666.67%
$573 Half Yearly Report and Accounts 2 Mar 2009 8:17AM $0.265 $7.470 risen by 2,718.87%
$573 Appendix 4C - quarterly 30 Jan 2009 4:57PM $0.270 $7.470 risen by 2,666.67%
$573 Appendix 4C - quarterly 31 Oct 2008 5:10PM $0.245 $7.470 risen by 2,948.98%
$573 Unilife Receives FDA Approval 24 Oct 2008 10:09AM $0.250 $7.470 risen by 2,888%
$573 Unilife Strengthens Strategic Business Plan 3 Oct 2008 3:54PM $0.250 $7.470 risen by 2,888%
$573 Appendix 4E - Preliminary Final Report (Y/E 30 June 2008) 28 Aug 2008 5:43PM $0.280 $7.470 risen by 2,567.86%
$573 Receipt of $16.4m Exclusivity Fee 4 Aug 2008 10:04AM $0.295 $7.470 risen by 2,432.20%
$573 Appendix 4C - quarterly 31 Jul 2008 5:11PM $0.280 $7.470 risen by 2,567.86%
$573 Unilife - 1mL Market Update 15 Jul 2008 9:20AM $0.295 $7.470 risen by 2,432.20%
$573 Unilife - 1mL Market Update 15 Jul 2008 9:20AM $0.295 $7.470 risen by 2,432.20%
$573 Unilife - Exclusive License Agreement with sanofi-aventis 1 Jul 2008 9:31AM $0.390 $7.470 risen by 1,815.38%
$573 Trading Halt 30 Jun 2008 9:51AM n/a $7.470 n/a
$573 Market Update on US Expansion Strategy and Director Appt 25 Jun 2008 12:38PM $0.380 $7.470 risen by 1,865.79%
$573 Response to ASX Query 17 Jun 2008 10:14AM $0.385 $7.470 risen by 1,840.26%
$573 Issue of Unsecured Convertible Note / Appendix 3B 10 Jun 2008 11:04AM $0.300 $7.470 risen by 2,390%
$573 Appendix 4C - quarterly 30 Apr 2008 4:37PM $0.245 $7.470 risen by 2,948.98%
$573 Unilife - Prefilled Syringe Market Update 7 Apr 2008 10:44AM $0.290 $7.470 risen by 2,475.86%
$573 Unilife - Production Update and FDA Submission 3 Apr 2008 10:41AM $0.295 $7.470 risen by 2,432.20%
$573 Half Year Report and Accounts 29 Feb 2008 4:59PM $0.275 $7.470 risen by 2,616.36%
$573 Appendix 4C - quarterly 31 Jan 2008 4:06PM $0.255 $7.470 risen by 2,829.41%
$573 1mL Production Update 29 Nov 2007 11:09AM $0.345 $7.470 risen by 2,065.22%

301 - 325 of 392 results

Page 13 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.